Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. (2022). Brazilian Journal of Pharmaceutical Sciences, 57. https://doi.org/10.1590/s2175-97902020000419078